dimercaprol has been researched along with Breast Neoplasms in 1 studies
Dimercaprol: An anti-gas warfare agent that is effective against Lewisite (dichloro(2-chlorovinyl)arsine) and formerly known as British Anti-Lewisite or BAL. It acts as a chelating agent and is used in the treatment of arsenic, gold, and other heavy metal poisoning.
dimercaprol : A dithiol that is propane-1,2-dithiol in which one of the methyl hydrogens is replaced by a hydroxy group. a chelating agent originally developed during World War II as an experimental antidote against the arsenic-based poison gas Lewisite, it has been used clinically since 1949 for the treatment of poisoning by arsenic, mercury and gold. It can also be used for treatment of poisoning by antimony, bismuth and possibly thallium, and (with sodium calcium edetate) in cases of acute leaad poisoning. Administration is by (painful) intramuscular injection of a suspension of dimercaprol in peanut oil, typically every 4 hours for 2-10 days depending on the toxicity. In the past, dimercaprol was also used for the treatment of Wilson's disease, a severely debilitating genetic disorder in which the body tends to retain copper, with resultant liver and brain injury.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to evaluate the antitumor activity of lipophilic bismuth nanoparticles (BisBAL NPs) on breast cancer cells." | 7.88 | In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells. ( Cabral-Romero, C; Chellam, S; García-Cuéllar, CM; Hernandez-Delgadillo, R; Martínez-Martínez, MA; Nakagoshi-Cepeda, MAA; Nakagoshi-Cepeda, SE; Pineda-Aguilar, N; Rangel-Padilla, EE; Sánchez-Nájera, RI; Sánchez-Pérez, Y; Solís-Soto, JM, 2018) |
| "The objective of this study was to evaluate the antitumor activity of lipophilic bismuth nanoparticles (BisBAL NPs) on breast cancer cells." | 3.88 | In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells. ( Cabral-Romero, C; Chellam, S; García-Cuéllar, CM; Hernandez-Delgadillo, R; Martínez-Martínez, MA; Nakagoshi-Cepeda, MAA; Nakagoshi-Cepeda, SE; Pineda-Aguilar, N; Rangel-Padilla, EE; Sánchez-Nájera, RI; Sánchez-Pérez, Y; Solís-Soto, JM, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hernandez-Delgadillo, R | 1 |
| García-Cuéllar, CM | 1 |
| Sánchez-Pérez, Y | 1 |
| Pineda-Aguilar, N | 1 |
| Martínez-Martínez, MA | 1 |
| Rangel-Padilla, EE | 1 |
| Nakagoshi-Cepeda, SE | 1 |
| Solís-Soto, JM | 1 |
| Sánchez-Nájera, RI | 1 |
| Nakagoshi-Cepeda, MAA | 1 |
| Chellam, S | 1 |
| Cabral-Romero, C | 1 |
1 other study available for dimercaprol and Breast Neoplasms
| Article | Year |
|---|---|
In vitro evaluation of the antitumor effect of bismuth lipophilic nanoparticles (BisBAL NPs) on breast cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Bismuth; Breast Neoplasms; Cell Membrane Permeability; Cell Surviv | 2018 |